Faron Pharmaceuticals Oy (OHEL:FARON) Cash From Discontinued Investing Activities : €0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Faron Pharmaceuticals Oy Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Faron Pharmaceuticals Oy's cash from discontinued investing activities for the six months ended in Jun. 2024 was €0.00 Mil. It means Faron Pharmaceuticals Oy received €0.00 Mil from discontinued investing activities. Faron Pharmaceuticals Oy's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Faron Pharmaceuticals Oy Cash From Discontinued Investing Activities Historical Data

The historical data trend for Faron Pharmaceuticals Oy's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faron Pharmaceuticals Oy Cash From Discontinued Investing Activities Chart

Faron Pharmaceuticals Oy Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash From Discontinued Investing Activities

Get a 7-Day Free Trial

Faron Pharmaceuticals Oy Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Cash From Discontinued Investing Activities	Get a 7-Day Free Trial															-	-	-	-	-

Faron Pharmaceuticals Oy Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Faron Pharmaceuticals Oy Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of Faron Pharmaceuticals Oy's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Faron Pharmaceuticals Oy Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Faron Pharmaceuticals Oy (OHEL:FARON) » Definitions » Cash From Discontinued Investing Activities

Comparable Companies

Traded in Other Exchanges

FARN:UK 4FR:Germany

Address

Joukahaisenkatu 6 B, Turku, FIN, 20520

Website

https://www.faron.com

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company developing novel treatments for medical conditions with unmet needs. The company has a pipeline based on the receptors involved in the regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy in phase I/II development as a novel macrophage checkpoint immunotherapy for patients with untreatable solid tumours, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Traumakine, the company's investigational intravenous interferon beta-1a is an anti-viral and anti-inflammatory agent, being tested for the prevention of complications that arise from cytokine release syndrome, or hyperinflammatory conditions.

Faron Pharmaceuticals Oy Headlines

No Headlines